252 related articles for article (PubMed ID: 28643714)
1. Comparison of vitrectomized with nonvitrectomized eyes after subtenon injection of triamcinolone acetonide to treat diabetic macular edema: Retrospective comparative Analysis of an interventional case series.
Pak KY; Choi BS; Park SW; Byon IS; Lee JE
Indian J Ophthalmol; 2017 Jun; 65(6):488-492. PubMed ID: 28643714
[TBL] [Abstract][Full Text] [Related]
2. Intravitreal versus posterior subtenon injection of triamcinolone acetonide for diabetic macular edema.
Choi YJ; Oh IK; Oh JR; Huh K
Korean J Ophthalmol; 2006 Dec; 20(4):205-9. PubMed ID: 17302204
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the magnitude and time course of macular thinning induced by different interventions for diabetic macular edema: implications for sequence of application.
Browning DJ; Fraser CM; Powers ME
Ophthalmology; 2006 Oct; 113(10):1713-9. PubMed ID: 16889833
[TBL] [Abstract][Full Text] [Related]
4. Intraocular pressure after intravitreal injection of triamcinolone acetonide following vitrectomy for macular edema.
Yamashita T; Uemura A; Kita H; Sakamoto T
J Glaucoma; 2007 Mar; 16(2):220-4. PubMed ID: 17473734
[TBL] [Abstract][Full Text] [Related]
5. Pars plana vitrectomy with internal limiting membrane peeling compared with intravitreal triamcinolone injection in the treatment of diabetic macular edema.
Kim YM; Chung EJ; Byeon SH; Lee SC; Kwon OW; Koh HJ
Ophthalmologica; 2009; 223(1):17-23. PubMed ID: 18849632
[TBL] [Abstract][Full Text] [Related]
6. Intravitreal vs. subtenon triamcinolone acetonide for the treatment of diabetic cystoid macular edema.
Cellini M; Pazzaglia A; Zamparini E; Leonetti P; Campos EC
BMC Ophthalmol; 2008 Mar; 8():5. PubMed ID: 18366650
[TBL] [Abstract][Full Text] [Related]
7. [Triamcinolone in the treatment of the diabetic macular edema--one-year results].
Dusová J; Studnicka J; Rencová E; Korda V; Hejcmanová D
Cesk Slov Oftalmol; 2008 Jul; 64(4):149-52. PubMed ID: 18780654
[TBL] [Abstract][Full Text] [Related]
8. Comparative study on efficacy of a combination therapy of triamcinolone acetonide administration with and without vitrectomy for macular edema associated with branch retinal vein occlusion.
Hirano Y; Sakurai E; Yoshida M; Ogura Y
Ophthalmic Res; 2007; 39(4):207-12. PubMed ID: 17596753
[TBL] [Abstract][Full Text] [Related]
9. Fluocinolone Acetonide Intravitreal Implant 190 μg (ILUVIEN®) in Vitrectomized versus Nonvitrectomized Eyes for the Treatment of Chronic Diabetic Macular Edema.
Pessoa B; Coelho J; Correia N; Ferreira N; Beirão M; Meireles A
Ophthalmic Res; 2018; 59(2):68-75. PubMed ID: 29248913
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of Intravitreal Triamcinolone Acetonide for Diabetic Macular Edema After Vitrectomy.
Watanabe A; Tsuzuki A; Arai K; Gekka T; Kohzaki K; Tsuneoka H
J Ocul Pharmacol Ther; 2016; 32(1):38-43. PubMed ID: 26325253
[TBL] [Abstract][Full Text] [Related]
11. Diabetic macular edema before and after intravitreal triamcinolone injection.
Ramezani A; Tabatabaie H; Ahmadieh H
Korean J Ophthalmol; 2007 Jun; 21(2):95-9. PubMed ID: 17592240
[TBL] [Abstract][Full Text] [Related]
12. Trans-Tenon's retrobulbar injection of triamcinolone acetonide for diffuse diabetic macular edema.
Wada M; Ogata N; Minamino K; Koriyama M; Higuchi A; Matsumura M
Jpn J Ophthalmol; 2005; 49(6):509-515. PubMed ID: 16365798
[TBL] [Abstract][Full Text] [Related]
13. Posterior subtenon and intravitreal triamcinolone acetonide for diabetic macular edema.
Ozdek S; Bahçeci UA; Gürelik G; Hasanreisoğlu B
J Diabetes Complications; 2006; 20(4):246-51. PubMed ID: 16798476
[TBL] [Abstract][Full Text] [Related]
14. Intravitreal triamcinolone acetonide for diabetic diffuse macular edema: preliminary results of a prospective controlled trial.
Massin P; Audren F; Haouchine B; Erginay A; Bergmann JF; Benosman R; Caulin C; Gaudric A
Ophthalmology; 2004 Feb; 111(2):218-24; discussion 224-5. PubMed ID: 15019365
[TBL] [Abstract][Full Text] [Related]
15. Intravitreal triamcinolone compared with macular laser grid photocoagulation for the treatment of cystoid macular edema.
Avitabile T; Longo A; Reibaldi A
Am J Ophthalmol; 2005 Oct; 140(4):695-702. PubMed ID: 16226521
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of 0.2 μg/day fluocinolone acetonide implant (ILUVIEN) in eyes with diabetic macular edema and prior vitrectomy.
Meireles A; Goldsmith C; El-Ghrably I; Erginay A; Habib M; Pessoa B; Coelho J; Patel T; Tadayoni R; Massin P; Atorf J; Augustin AJ
Eye (Lond); 2017 May; 31(5):684-690. PubMed ID: 28085139
[TBL] [Abstract][Full Text] [Related]
17. Recurrence of diabetic macular edema after intravitreous injection of triamcinolone following vitrectomy.
Shimonagano Y; Doi N; Noda Y; Uemura A; Sakamoto T
Jpn J Ophthalmol; 2007; 51(4):278-84. PubMed ID: 17660988
[TBL] [Abstract][Full Text] [Related]
18. Changes in aqueous concentrations of various cytokines after intravitreal bevacizumab and subtenon triamcinolone injection for diabetic macular edema.
Yu SY; Nam DH; Lee DY
Graefes Arch Clin Exp Ophthalmol; 2018 Jan; 256(1):39-47. PubMed ID: 29030692
[TBL] [Abstract][Full Text] [Related]
19. [Comparison of pars plana vitrectomy with ILM peeling and intravitreal triamcinolone in diffuse diabetic macular oedema].
Khurieva-Sattler E; Krause M; Löw U; Gatzioufas Z; Toropygin S; Seitz B; Ruprecht K; Hille K
Klin Monbl Augenheilkd; 2010 Jun; 227(6):496-500. PubMed ID: 20221984
[TBL] [Abstract][Full Text] [Related]
20. Dexamethasone intravitreal implant in vitrectomized versus nonvitrectomized eyes for treatment of patients with persistent diabetic macular edema.
Medeiros MD; Alkabes M; Navarro R; Garcia-Arumí J; Mateo C; Corcóstegui B
J Ocul Pharmacol Ther; 2014 Nov; 30(9):709-16. PubMed ID: 25259834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
